Opaleye Management Inc.
10% Owner

Opaleye Management Inc. insider trades: Grace Therapeutics (GRCE) stock buys and sales

10% Owner, Grace Therapeutics Last trade Nov 5, 2026 216 Form 4 filings
$25.3M
Sold, last 12 months
24 sales
$19.1M
Bought, last 12 months
60 buys
320
Open-market trades
since 2015
16
Companies
last trade 2026

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Opaleye Management Inc. reports to the SEC

and 10 more companies

Open-market buys and sales

320 trades reported on SEC Form 4, newest first

DateStockTypeValue
Nov 5, 2026GRCE↑ Buy$33K
Oct 26, 2026GRCE↑ Buy$159K
Oct 23, 2026ACOG↑ Buy$266K
Oct 19, 2026GRCE↑ Buy$8K
Oct 16, 2026ACOG↑ Buy$309K
Oct 16, 2026GRCE↑ Buy$136K
Oct 12, 2026GRCE↑ Buy$30K
Oct 5, 2026GRCE↑ Buy$124K
Oct 1, 2026ACOG↑ Buy$166K
Sep 29, 2026GRCE↑ Buy$16K
Sep 25, 2026ACOG↑ Buy$271K
Sep 23, 2026GRCE↑ Buy$32K
Sep 23, 2026GRCE↑ Buy$32K
Sep 16, 2026ACOG↑ Buy$1.1M
Sep 11, 2026SLGL↑ Buy$207K
Sep 2, 2026SLGL↑ Buy$116K
Aug 31, 2026SLGL↑ Buy$2.8M
Aug 14, 2026GRCE↑ Buy$24K
Aug 12, 2026SLGL↑ Buy$68K
Aug 3, 2026ACOG↑ Buy$423K
Jul 23, 2026ACOG↑ Buy$1.5M
Jul 22, 2026ACOG↑ Buy$78K
Jul 14, 2026ETON↓ Sell$563K
Jul 14, 2026ETON↓ Sell$500K
Jul 14, 2026ETON↓ Sell$563K
Jul 14, 2026ETON↓ Sell$500K
Jul 14, 2026SLGL↑ Buy$125K
Jul 10, 2026SLGL↑ Buy$39K
Jul 7, 2026ETON↓ Sell$3.6M
Jul 7, 2026ETON↓ Sell$1.2M
Jul 2, 2026SLGL↑ Buy$123K
Jun 26, 2026ACOG↑ Buy$976K
Jun 15, 2026ACOG↑ Buy$46K
Jun 10, 2026ACOG↑ Buy$184K
Jun 5, 2026ACOG↑ Buy$59K
May 29, 2026ACOG↑ Buy$435K
May 21, 2026ACOG↑ Buy$141K
May 20, 2026SLGL↑ Buy$101K
May 18, 2026ACOG↑ Buy$196K
May 13, 2026SLGL↑ Buy$232K
Apr 29, 2026SNWV↓ Sell$1.2M
Apr 29, 2026SNWV↓ Sell$63K
Apr 21, 2026SNWV↓ Sell$235K
Apr 17, 2026SNWV↓ Sell$102K
Mar 30, 2026ACOG↑ Buy$60K
Mar 24, 2026SLGL↑ Buy$2.5M
Mar 24, 2026SLGL↑ Buy$360K
Mar 19, 2026ACOG↑ Buy$26K
Mar 16, 2026ACOG↑ Buy$8K
Mar 9, 2026ACOG↑ Buy$24K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

About Opaleye Management Inc.'s insider trades

Opaleye Management Inc. is a 10% owner of Grace Therapeutics (GRCE). Since May 19, 2015, it has reported 249 open-market purchases worth $69.4M and 71 sales worth $41.2M on SEC Form 4. In the last 12 months: 60 buys ($19.1M) and 24 sales ($25.3M).

Its filings also include option exercises (1 filing), other transactions (1 filing). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every GRCE insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.